Press Releases
14 November 2019
SILVER SPRING, Md., Nov. 14, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has issued a
Read more...14 November 2019
BOSTON, Nov. 14, 2019 /PRNewswire/ -- PatientPing, the nation's leading care collaboration and e-notifications platform, is recognized as a Higher Performing Emerging Healthcare IT company in the new KLAS® Research spotlight report "
Read more...NEW YORK, Nov. 14, 2019 /PRNewswire/ -- Mutual of America announced the recipients of its 2019 Community Partnership Award, wh
Read more...14 November 2019
ELIZABETH, Colo., Nov. 14, 2019 /PRNewswire/ -- Viscos, LLC, a nutritional supplement company committed to scientific research and development of lifestyle recovery products for a variety of health issues using an oral, liquid high-molecular weight hyaluronan (HMW-HA) combined with other natural ingredients. After six years of research and development we are p
Read more...14 November 2019
WASHINGTON, Nov. 14, 2019 /PRNewswire/ -- As a powerful arctic cold front sweeps through the country, emergency physicians are urging people to understand cold weather health risks and take precautions to avoid cold-related medical emergencies.
Read more...14 November 2019
MANHASSET, N.Y., Nov. 14, 2019 /PRNewswire/ -- The Feinstein Institutes for Medical Research Professor
Read more...14 November 2019
NORTH ANDOVER, Mass., Nov. 14, 2019 /PRNewswire/ -- According to Acelleron's latest Human Resources Report, 90 percent of breastfeeding moms are either pumping at work, or are planning to pump at work, despite breastfeeding being one of the biggest challenges when returning to work from parental leave.
Read more...14 November 2019
TEMPE, Ariz., Nov. 14, 2019 /PRNewswire/ -- In recognition of its compliance to industry standards, best practices and customer requirements for medical device quality and safety, Benchmark Ele
Read more...14 November 2019
SAN RAFAEL, Calif., Nov. 14, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) updated the investment community on the Company's research and development portfolio, which is focused on innovative therapies to treat rare diseases.
Read more...
